We are live on
!
Find out more
IE
Israel Englander Millennium Management
AUM
$276B
1-Year Est. Return
44.8%
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
This Fund
S&P 500
This Quarter
Est. Return
+7.92%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$203B
AUM Growth
+$28.4B
(+16%)
Cap. Flow
+$3.36B
Cap. Flow
% of AUM
1.66%
Top 10 Holdings %
Top 10 Hldgs %
26.11%
Holding
7,181
New
870
Increased
2,213
Reduced
2,337
Closed
1,192
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Blend Labs
BLND
$360M
| $3.26M | ﹤0.01% |
3,446,136
+3,338,357
| +3,097% | +$2.96M |
|
3002
PUT
Bank OZK
OZK
$5.39B
| $3.25M | ﹤0.01% |
+80,900
| New | +$2.9M |
|
3003
PUT
Inspire Medical Systems
INSP
$1.78B
| $3.25M | ﹤0.01% |
+10,000
| New | +$2.86M |
|
3004
iShares MSCI China ETF
MCHI
$6.25B
| $3.25M | ﹤0.01% |
72,544
-175,943
| -71% | -$8.23M |
|
|
NVO
3005
PUT
Novo Nordisk
NVO
$202B
| $3.24M | ﹤0.01% |
40,000
+25,400
| +174% | +$2.07M |
|
3006
State Street Blackstone Senior Loan ETF
SRLN
$5.48B
| $3.24M | ﹤0.01% |
77,301
-51,095
| -40% | -$2.11M |
|
3007
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$299M
| $3.23M | ﹤0.01% |
110,001
+51,000
| +86% | +$1.49M |
|
|
SEM
3008
DELISTED
Select Medical
SEM
| $3.23M | ﹤0.01% |
188,289
+76,951
| +69% | +$1.19M |
|
3009
PUT
Martin Marietta Materials
MLM
$37.7B
| $3.23M | ﹤0.01% |
7,000
+5,000
| +250% | +$1.97M |
|
|
DJTWW
3010
CALL
Trump Media & Technology Group Warrants
DJTWW
$1.05B
| $3.23M | ﹤0.01% |
1,242,766
| – | – |
|
3011
Amerant Bancorp
AMTB
$1.13B
| $3.23M | ﹤0.01% |
187,854
-62,678
| -25% | -$1.17M |
|
3012
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.14B
| $3.22M | ﹤0.01% |
128,945
-162,132
| -56% | -$4.25M |
|
3013
Newell Brands
NWL
$2.63B
| $3.22M | ﹤0.01% |
370,246
-1,952,422
| -84% | -$19.4M |
|
3014
PUT
GE HealthCare
GEHC
$32.4B
| $3.22M | ﹤0.01% |
+39,600
| New | +$3.16M |
|
3015
Expensify
EXFY
$235M
| $3.21M | ﹤0.01% |
402,880
-543,899
| -57% | -$3.99M |
|
|
CHEA
3016
DELISTED
Chenghe Acquisition Co. Class A Ordinary Share
CHEA
| $3.21M | ﹤0.01% |
300,000
| – | – |
|
3017
CALL
Glaukos
GKOS
$10.6B
| $3.2M | ﹤0.01% |
+45,000
| New | +$2.58M |
|
3018
Scholastic
SCHL
$735M
| $3.2M | ﹤0.01% |
82,352
+69,280
| +530% | +$2.69M |
|
3019
GrafTech
EAF
$193M
| $3.2M | ﹤0.01% |
63,406
-13,473
| -18% | -$627K |
|
|
CITE
3020
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
| $3.19M | ﹤0.01% |
300,000
| – | – |
|
3021
Amneal Pharmaceuticals
AMRX
$6.11B
| $3.19M | ﹤0.01% |
1,028,641
-2,065,044
| -67% | -$4.4M |
|
3022
Westamerica Bancorp
WABC
$1.34B
| $3.19M | ﹤0.01% |
83,230
-227,894
| -73% | -$9.11M |
|
3023
PUT
Monolithic Power Systems
MPWR
$61.7B
| $3.19M | ﹤0.01% |
+5,900
| New | +$2.8M |
|
|
MORF
3024
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $3.18M | ﹤0.01% |
55,552
+22,419
| +68% | +$1.17M |
|
|
TRTX
3025
TPG RE Finance Trust
TRTX
$593M
| $3.18M | ﹤0.01% |
429,767
+292,891
| +214% | +$1.98M |
|
Similar funds
JT
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.